Log In
BCIQ
Print this Print this
 

NeutroPhase (NVC-101)

  Manage Alerts
Collapse Summary General Information
Company NovaBay Pharmaceuticals Inc.
DescriptionStabilized form of hypochlorous acid in saline
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationWounds
Indication DetailsPromote wound healing
Regulatory Designation
PartnerChina Pioneer Pharma Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.3M

$0.3M

$1.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/16/2012

$1.3M

$0.3M

$1.0M

Get a free BioCentury trial today